ASTRAZEN technical summary

At ₹6,299, AstraZeneca Pharma India Limited is trading 3.4% below its 50-day average of ₹6,523.27 and 20.5% below its 200-day average of ₹7,922.16. The 14-day RSI is 53.9, in the neutral range between 30 and 70. MACD is -106.39 against a signal line of -184.56, so the MACD line sits above its signal line. ADX(14) reads 48.6, a strong trend reading (25 or above); ADX measures trend strength, not direction. The 52-week range is ₹5,640 to ₹9,849.5, with the price 16% of the way up it. Classic daily pivot levels from the 29 Oct 2026 session: pivot ₹6,259.17, resistance ₹6,348.33 and ₹6,459.67, support ₹6,147.83 and ₹6,058.67.